Berenberg Bank Reiterates “Buy” Rating for ANGLE (LON:AGL)

ANGLE (LON:AGL)‘s stock had its “buy” rating reissued by equities researchers at Berenberg Bank in a report released on Wednesday, Marketbeat reports. They currently have a GBX 40 ($0.50) price target on the stock. Berenberg Bank’s price target suggests a potential upside of 174.56% from the company’s current price.

ANGLE Price Performance

AGL stock opened at GBX 14.57 ($0.18) on Wednesday. The business’s fifty day moving average price is GBX 11.03 and its 200 day moving average price is GBX 11.17. ANGLE has a 12-month low of GBX 7.11 ($0.09) and a 12-month high of GBX 25.13 ($0.31). The company has a current ratio of 5.19, a quick ratio of 6.18 and a debt-to-equity ratio of 17.22. The company has a market capitalization of £46.99 million, a PE ratio of -208.13 and a beta of 0.22.

ANGLE Company Profile

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.